The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a (68)Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size

INTRODUCTION: At present, there is no approved medical treatment option for patients with non-functioning pituitary adenoma. A number of open-label studies suggest that treatment with somatostatin analogues may prevent tumour progression. In vivo somatostatin receptor imaging using (68)Ga-DOTATATE P...

Descripción completa

Detalles Bibliográficos
Autores principales: Boertien, Tessel M, Drent, Madeleine L, Booij, Jan, Majoie, Charles B L M, Stokkel, Marcel P M, Hoogmoed, Jantien, Pereira, Alberto, Biermasz, Nienke R, Simsek, Suat, Groote Veldman, Ronald, Tanck, Michael W T, Fliers, Eric, Bisschop, Peter H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430490/
https://www.ncbi.nlm.nih.gov/pubmed/32792446
http://dx.doi.org/10.1136/bmjopen-2020-038250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430490/
https://www.ncbi.nlm.nih.gov/pubmed/32792446
http://dx.doi.org/10.1136/bmjopen-2020-038250

Ejemplares similares